Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver

被引:42
作者
Cain, D
Hutson, SM
Wallin, R
机构
[1] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA
关键词
D O I
10.1055/s-0037-1615151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Warfarin. the most used drug in the world in long-term anticoagulation prophylaxis. targets the vitamin K 2,3-epoxide reductase (VKOR) of the vitamin K cycle in liver. Recently, the enzyme has been identified as a multicomponent lipid-protein enzyme system in the endoplasmic reticulum (ER) membrane (17). As the first step towards understanding genetic resistance to warfarin, we present in this paper data on VKOR from normal and a strain of warfarin resistant laboratory rats maintained in the United States. Metal induced in vitro assembly of the enzyme complex demonstrates that the glutathione-S-transferase (GST) enzyme component of the complex loses its GST activity upon formation of VKOR. Less VKOR activity is measured upon assembly of the complex from warfarin resistant rats. The GST activity measured in warfarin resistant rats, before assembly of the complex. is 10-fold less sensitive to warfarin inhibition than the GST activity measured in normal rats. Microsomal epoxide hydrolase (mEH) is the second component of VKOR. When incubated with the components of VKOR before assembly of the complex, antibodies raised against mEH prevented formation of the enzyme complex. Sequencing of mEH cDNAs from normal and warfarin resistant rats revealed identical sequences. The data suggest that the mutation responsible for genetic warfarin resistance is associated with the GST component of VKOR.
引用
收藏
页码:128 / 133
页数:6
相关论文
共 33 条
  • [1] 5-LIPOXYGENASE-ACTIVATING PROTEIN STIMULATES THE UTILIZATION OF ARACHIDONIC-ACID BY 5-LIPOXYGENASE
    ABRAMOVITZ, M
    WONG, E
    COX, ME
    RICHARDSON, CD
    LI, C
    VICKERS, PJ
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 215 (01): : 105 - 111
  • [2] ALVES C, 1993, J BIOL CHEM, V268, P20148
  • [3] HEREDITARY WARFARIN RESISTANCE - INVESTIGATION OF A RARE PHENOMENON
    ALVING, BM
    STRICKLER, MP
    KNIGHT, RD
    BARR, CF
    BERENBERG, JL
    PECK, CC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (03) : 499 - 501
  • [4] KINETIC-STUDIES ON RAT-LIVER MICROSOMAL GLUTATHIONE TRANSFERASE - CONSEQUENCES OF ACTIVATION
    ANDERSSON, C
    PIEMONTE, F
    MOSIALOU, E
    WEINANDER, R
    SUN, TH
    LUNDQVIST, G
    ADANG, AEP
    MORGENSTERN, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1247 (02): : 277 - 283
  • [5] ORAL ANTICOAGULANT-THERAPY - 50 YEARS LATER
    ANSELL, JE
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (05) : 586 - 596
  • [6] Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane
    Cain, D
    Hutson, SM
    Wallin, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) : 29068 - 29075
  • [7] Expression of recombinant elongation factor 1 beta from rabbit in Escherichia coli. Phosphorylation by casein kinase II
    Chen, CJ
    Traugh, JA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1264 (03): : 303 - 311
  • [8] WARFARIN INHIBITION OF VITAMIN-K 2,3-EPOXIDE REDUCTASE IN RAT-LIVER MICROSOMES
    FASCO, MJ
    PRINCIPE, LM
    WALSH, WA
    FRIEDMAN, PA
    [J]. BIOCHEMISTRY, 1983, 22 (24) : 5655 - 5660
  • [9] THE MOLECULAR-BASIS OF BLOOD-COAGULATION
    FURIE, B
    FURIE, BC
    [J]. CELL, 1988, 53 (04) : 505 - 518
  • [10] NOVEL 4-HYDROXYCOUMARIN ANTICOAGULANTS ACTIVE AGAINST RESISTANT RATS
    HADLER, MR
    SHADBOLT, RS
    [J]. NATURE, 1975, 253 (5489) : 275 - 277